BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19911991)

  • 1. Dengue virus infections and maternal antibody decay in a prospective birth cohort study of Vietnamese infants.
    Chau TN; Hieu NT; Anders KL; Wolbers M; Lien le B; Hieu LT; Hien TT; Hung NT; Farrar J; Whitehead S; Simmons CP
    J Infect Dis; 2009 Dec; 200(12):1893-900. PubMed ID: 19911991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.
    Castanha PM; Braga C; Cordeiro MT; Souza AI; Silva CD; Martelli CM; van Panhuis WG; Nascimento EJ; Marques ET
    J Infect Dis; 2016 Jul; 214(2):265-72. PubMed ID: 27056951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.
    Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ
    PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Persistence of Maternal Dengue Neutralizing Antibodies in Infants From Central and Southern Thailand: A Retrospective Cohort Study.
    Guignard A; Haguinet F; Wéry S; Kerdpanich P
    Asia Pac J Public Health; 2019 May; 31(4):288-295. PubMed ID: 31307216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal Passive Immunity and Dengue Hemorrhagic Fever in Infants.
    Adimy M; Mancera PFA; Rodrigues DS; Santos FLP; Ferreira CP
    Bull Math Biol; 2020 Jan; 82(2):24. PubMed ID: 31993759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between dengue-specific neutralizing antibodies and serum avidity in primary and secondary dengue virus 3 natural infections in humans.
    Puschnik A; Lau L; Cromwell EA; Balmaseda A; Zompi S; Harris E
    PLoS Negl Trop Dis; 2013; 7(6):e2274. PubMed ID: 23785536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infections.
    Libraty DH; Zhang L; Obcena A; Brion JD; Capeding RZ
    Acta Trop; 2015 Feb; 142():103-7. PubMed ID: 25460346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.
    Tsai WY; Durbin A; Tsai JJ; Hsieh SC; Whitehead S; Wang WK
    J Virol; 2015 Jul; 89(14):7348-62. PubMed ID: 25972550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dengue antibody in Thai children from maternally transferred antibody to acquired infection.
    Pengsaa K; Limkittikul K; Yoksan S; Wisetsing P; Sabchareon A
    Pediatr Infect Dis J; 2011 Oct; 30(10):897-900. PubMed ID: 21552182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High frequency of pre-existing neutralizing antibody responses in patients with dengue during an outbreak in Central Brazil.
    de Teive E Argolo AF; de Rezende Féres VC; Cordeiro MT; da Silveira LA; Guilarde AO; de Azevedo Marques ET; de Souza WV; Martelli CM
    BMC Infect Dis; 2016 Oct; 16(1):546. PubMed ID: 27717314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice.
    Fowler AM; Tang WW; Young MP; Mamidi A; Viramontes KM; McCauley MD; Carlin AF; Schooley RT; Swanstrom J; Baric RS; Govero J; Diamond MS; Shresta S
    Cell Host Microbe; 2018 Nov; 24(5):743-750.e5. PubMed ID: 30439343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological characterization of dengue virus infections observed among dengue hemorrhagic fever/dengue shock syndrome cases in upper Myanmar.
    Ngwe Tun MM; Thant KZ; Inoue S; Kurosawa Y; Lwin YY; Lin S; Aye KT; Thet Khin P; Myint T; Htwe K; Mapua CA; Natividad FF; Hirayama K; Morita K
    J Med Virol; 2013 Jul; 85(7):1258-66. PubMed ID: 23595687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay and persistence of maternal dengue antibodies among infants in Bangkok.
    van Panhuis WG; Luxemburger C; Pengsaa K; Limkittikul K; Sabchareon A; Lang J; Durbin AP; Cummings DA
    Am J Trop Med Hyg; 2011 Aug; 85(2):355-62. PubMed ID: 21813859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sera of patients with systemic lupus erythematosus cross-neutralizes dengue viruses.
    Zainal N; Tan KK; Johari J; Hussein H; Wan Musa WR; Hassan J; Lin YS; AbuBakar S
    Microbiol Immunol; 2018 Oct; 62(10):659-672. PubMed ID: 30259549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perinatal analyses of Zika- and dengue virus-specific neutralizing antibodies: A microcephaly case-control study in an area of high dengue endemicity in Brazil.
    Castanha PMS; Souza WV; Braga C; Araújo TVB; Ximenes RAA; Albuquerque MFPM; Montarroyos UR; Miranda-Filho DB; Cordeiro MT; Dhalia R; Marques ETA; Rodrigues LC; Martelli CMT;
    PLoS Negl Trop Dis; 2019 Mar; 13(3):e0007246. PubMed ID: 30856223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Zika virus neutralizing antibodies in healthy adults in Vietnam during and after the Zika virus epidemic season: a longitudinal population-based survey.
    Nguyen CT; Moi ML; Le TQM; Nguyen TTT; Vu TBH; Nguyen HT; Pham TTH; Le THT; Nguyen LMH; Phu Ly MH; Ng CFS; Takemura T; Morita K; Hasebe F
    BMC Infect Dis; 2020 May; 20(1):332. PubMed ID: 32393198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection.
    Moi ML; Takasaki T; Saijo M; Kurane I
    Trans R Soc Trop Med Hyg; 2013 Jan; 107(1):51-8. PubMed ID: 23296697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody fucosylation predicts disease severity in secondary dengue infection.
    Bournazos S; Vo HTM; Duong V; Auerswald H; Ly S; Sakuntabhai A; Dussart P; Cantaert T; Ravetch JV
    Science; 2021 Jun; 372(6546):1102-1105. PubMed ID: 34083490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dengue virus infection-enhancement activity in neutralizing antibodies of healthy adults before dengue season as determined by using FcγR-expressing cells.
    Ly MHP; Moi ML; Vu TBH; Tun MMN; Saunders T; Nguyen CN; Nguyen AKT; Nguyen HM; Dao TH; Pham DQ; Nguyen TTT; Le TQM; Hasebe F; Morita K
    BMC Infect Dis; 2018 Jan; 18(1):31. PubMed ID: 29321001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.